VIRX - Viracta Therapeutics GAAP EPS of -$0.23
2024-05-09 17:36:13 ET
More on Viracta Therapeutics
- Day One wins FDA nod for brain cancer therapy, Ojemda
- Viracta slides on lower response rate in trial for lymphoma treatment cohort
- Seeking Alpha’s Quant Rating on Viracta Therapeutics
- Historical earnings data for Viracta Therapeutics
- Financial information for Viracta Therapeutics